Head-to-head · Cost-Efficiency Index
Harbor vs Revel Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Harbor
Cost-first shoppers who want price-sensitive shoppers who want a 'locked, no-increase' pricing promise on entry-tier compounded GLP-1s.
Visit HarborRevel Health
Cost-first shoppers who want gLP-1 weight loss bundled with longevity add-ons, if the first-month promo price isn't mistaken for the ongoing rate.
Visit Revel HealthThe verdict
Harbor and Revel Health tie on the Cost-Efficiency Index at 69/100, so neither wins outright on the numbers. For most shoppers we'd start with Harbor (ranked #100, a hair above #107) — Cost-first shoppers who want price-sensitive shoppers who want a 'locked, no-increase' pricing promise on entry-tier compounded GLP-1s. But Revel Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Harbor.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Harbor | Revel Health |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 69/100 |
| Semaglutide / mo | $99/mo (starting dose, compounded) | $199/mo (starting dose, promotional rate, compounded) |
| Tirzepatide / mo | $149/mo (starting dose, compounded) | $249/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $1,188 | $2,388 |
| Tirzepatide / yr (modeled) | $1,788 | $2,988 |
| Coverage | Coverage not published | 45 states |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #100 | #107 |
Harbor
69/100Where the value is
- Among the lowest entry-tier prices seen in this set ($99 semaglutide / $149 tirzepatide)
- Explicit 'No Price Increases / Locked pricing' claim, addressing a common bait-and-switch risk
- LegitScript badge verifiably tied to the visitharbor.com domain itself
The tradeoffs
- 'As low as' framing without a visible full pricing/tier page (404'd)
- No individual is designated 'medical director' despite three physicians being pictured
Revel Health
69/100Where the value is
- All-in pricing confirmed on-site — consultation, medication, supplies, and shipping in one number, no add-on fees disclosed
- LegitScript verification seal is live and checkable for myrevelhealth.com
- Explicit, specific 45-state coverage list published rather than a vague claim
The tradeoffs
- The prominently displayed $99/$149 figures are first-month-only promotional prices — the standing rate from month two on is $199/$249, and the page's side-by-side display makes the promo easy to mistake for the ongoing price
- Not available in AK, AR, NC, NJ, or MS
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.